A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
about
Identification of cellular genes targeted by KSHV-encoded microRNAsTargeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaPhysical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANASmad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesionLatency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virusKaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesThe viral etiology of AIDS-associated malignanciesKSHV-Mediated Angiogenesis in Tumor ProgressionThe Modulation of Apoptotic Pathways by GammaherpesvirusesCell Cycle Regulatory Functions of the KSHV Oncoprotein LANAKSHV Genome Replication and MaintenanceThe modulation of apoptosis by oncogenic virusesKSHV: pathways to tumorigenesis and persistent infectionHepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcriptionRegulation of Wnt/β-catenin signaling by herpesvirusesKaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasionRapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteinsComprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistenceAngiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated HerpesvirusRemodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.GSK-3: Functional Insights from Cell Biology and Animal Models.Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.The "histone mimicry" by pathogens.Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latencyNFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathwayKaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoterKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latencyActivation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).View and review on viral oncology research.Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigenViral latency and its regulation: lessons from the gamma-herpesviruses.Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activator
P2860
Q21131610-1BDE62FB-B1B4-430B-BEBC-F7B48615E045Q21135231-F095A941-C8C0-4872-A45F-B4BAD0E1DFF4Q24299259-5DAE13C0-8BD2-4C76-8E39-ADE1771D61CFQ24309031-B6C77E6B-0D22-4ACA-B58B-51EEEB7C9AACQ24670086-9CB83748-1CB1-4808-84FA-69E8BC1CE99CQ24673761-DA39A4FB-4F14-4A83-9ED9-1C24D776B663Q24685892-955682AA-6367-4065-840C-847995105E29Q26742030-6F214C2B-314E-41FB-B040-CFAB1C7B0154Q26747452-0447825D-4630-431C-A2E9-84E53758DCCCQ26749612-71BC83BC-E463-4641-8CBC-AB869AC5A288Q26766437-CFB546D1-9483-48DB-8351-6E38540C5549Q26995410-0AAC9637-D18B-4461-B406-145B2052AE70Q27026000-D45129D8-B262-44BE-A8DF-BA257A3ACB5CQ27469443-392BD624-446A-4ED0-A4C5-3B68F6293FC5Q28079414-FAF9AF1C-EA56-4E98-B27A-7C56BD488F94Q28472867-49E0E6E4-709B-4C8B-8386-B6EDA4BF64F3Q28476740-287BBFD4-5CC6-424B-B1E1-8EB3D83A5E97Q28485399-9B698A1B-C333-4A39-8F57-2CB3AE924630Q28533244-6F553125-C6C2-424C-A388-F43B6342DEB2Q28750291-001E3985-F78B-485C-9279-E93B01E2D732Q30439948-3222CEAE-B241-4D17-94DE-44EDA72D9A98Q30472813-5D1C6047-304F-4288-B53D-31DFB0BD2385Q31156919-1882D1E6-345E-477E-BC34-FD989087FA36Q33261811-FBB3AE44-F72B-4F96-B3EA-4EC08F409005Q33282107-14F74FB5-1B9A-4B6A-9E88-D6A24CB97CFEQ33560572-D737F3E4-CEB0-414A-B7B8-6929BD34F08DQ33606391-E2B27804-2A78-43AA-AC68-7B11282E515BQ33632932-22B645F7-50ED-4431-9B27-066DA393EE4FQ33718186-F302486E-12A0-4AD6-8E89-C0CAC3511572Q33737793-9DCE3BCA-F4EE-4E0D-AEA7-BFC2E0331AFCQ33744019-E6AA70AB-8DC6-4A5A-A669-1047BA8DC0D9Q33748042-D15E8EFF-1D45-4E48-954A-5446FDF1EAA0Q33761091-001340EF-6ED3-46F1-9A5E-509EAE820456Q33843211-79D4E657-E54F-46B5-A4A5-1DD46DA0BD11Q33843421-100B765E-4F54-4730-AC5B-84839C9FA73CQ33894872-18DBD0C9-6092-4648-A520-C4A993C85798Q34013830-6C75B71E-6C07-468B-BF82-C4D07B7A5734Q34022999-327C506B-FDDB-481B-82C3-8A4BDBC25320Q34039189-ECE64F3D-80D1-4C8F-B78E-53392AA28FC3Q34055674-42C99E0E-271A-4A0B-AA32-01DEBDBC6CC5
P2860
A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@ast
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@en
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@nl
type
label
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@ast
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@en
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@nl
prefLabel
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@ast
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@en
A novel viral mechanism for dy ...... ssociated herpesvirus latency.
@nl
P2093
P356
P1433
P1476
A novel viral mechanism for dy ...... associated herpesvirus latency
@en
P2093
Colette ApRhys
David B Young
Frederick Y Wu
Gary S Hayward
Masahiro Fujimuro
S Diane Hayward
P2888
P304
P356
10.1038/NM829
P407
P577
2003-02-18T00:00:00Z